CLU and neuroblastoma: MiR-137 targets the EZH2 3′UTR in neuroblastoma cells, leading to decreased H3K27 methylation in the genomic regions of tumor suppressor genes clusterin (CLU) and nerve growth factor receptor (NGFR).